Chile Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Exotic travel ideas. Searching for your next vacation destination? Subscribe to Off The Beaten Path, a newsletter featuring captivating locales to help you to plan your next trip. From our sponsors

Chile Pharmaceuticals and Healthcare Report Q4 2013 Oct 2nd 2013, 00:00, by swapnil BMI View: Despite the slowdown in economic growth, Chile has accelerated the pace it is improving public healthcare standards at. However, poor quality medicines still proliferate in Chile’s pharmaceutical market due to the lack of vigilance in bioequivalence regulations. Local pharmaceutical companies’ low capacity has opened doors for foreign drugmakers to enter the Chilean drug market. Headline Expenditure Projections ? Pharmaceuticals: CLP1,605bn (US$3.3bn) in 2012 to CLP1,722bn (US$3.5bn) in 2013; +7.3% in local currency terms and +5.0% in US dollar terms. ? Healthcare: CLP9,825bn (US$20.2bn) in 2012 to CLP10,498bn (US$21.1bn) in 2013; +6.8% in local currency terms and +4.5% in … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=118126. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/chile-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions